on BIOSYNEX (EPA:ALBIO)
Launch of the capital increase by BIOSYNEX SA

BIOSYNEX SA has announced a capital increase with preferential subscription rights for a target amount of 7.99 million euros. This operation aims to strengthen its balance sheet and finance its working capital requirements. The unit subscription price is set at 1.00 euros, with a discount of 48% compared to the average price of 1.91 euros over the last 35 trading sessions.
The subscription period is scheduled from January 28 to February 7, 2025. The subscription commitment totals €6.0 million, supported mainly by Larry Abensur and a new investor for €4.6 million and €1.4 million respectively.
The Financial Markets Authority has granted Larry Abensur an exemption from the obligation to file a public takeover bid. This capital increase may result in a dilution of existing shares, as specified in the terms of the transaction.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BIOSYNEX news